BEIJING — Here are the latest developments on the novel coronavirus disease (COVID-19) in China:

— The city of Wuhan, the former epicenter of the outbreak in Central China, on April 17 revised its numbers of confirmed COVID-19 cases and deaths.

The total number of confirmed COVID-19 cases in the city as of the end of April 16 was revised up by 325 to 50,333, and the number of fatalities up by 1,290 to 3,869.

— The National Health Commission (NHC) received reports of 26 new confirmed COVID-19 cases on the mainland on April 16, of which 15 were imported.

Among the other 11 cases that were domestically transmitted, five were reported in Guangdong province, three in Heilongjiang province, two in Shandong province and one in Liaoning province.

— As of April 16, the Chinese mainland had reported a total of 1,549 imported cases. Of them, 670 had been discharged from hospitals after recovery, 879 were being treated with 45 in severe condition.

— Also on April 16, 66 new asymptomatic cases, including three from abroad, were reported on the mainland. The NHC said 1,038 asymptomatic cases, including 206 from abroad, were still under medical observation.

— By April 16, 1,017 confirmed cases including four deaths had been reported in the Hong Kong Special Administrative Region (SAR), 45 confirmed cases in the Macao SAR, and 395 in Taiwan including six deaths.

A total of 485 patients in Hong Kong, 16 in Macao and 155 in Taiwan had been discharged from hospitals after recovery.

— No new confirmed cases were reported in Central China's Hubei province on April 16. The provincial health commission said Hubei had 610 asymptomatic cases under medical observation by April 16, adding that 32 such cases were reported on April 16.

— Wuhan will hand out vouchers worth 500 million yuan ($70.6 million) to boost consumption, according to the municipal bureau of commerce.

Starting on April 19, all people in Wuhan, including non-locals, will be able to apply and use the vouchers, a move aimed to support the operation resumption in commercial, trade, cultural and tourism sectors.

— A "mobile hospital" was recently put into use in the city of Suifenhe, at the China-Russia border in Northeast China's Heilongjiang province, to assist local medics in treating COVID-19.

The hospital, developed by China Aerospace Science and Industry Corporation, was dispatched by the First Hospital of China Medical University. It consists of a remote consultation vehicle and an X-ray vehicle.

— A branch company of China's largest oil and gas producer PetroChina put into operation a new production line of melt-blown nonwoven fabric in Northeast China's Liaoning province on April 16.

It is expected to manufacture 500 metric tons of melt-blown nonwoven fabric a year. Another production line with the same annual capacity is being built to further boost the raw material supply to mask producers, according to PetroChina Liaoyang Petrochemical Company.

— Beijing reported three new COVID-19 cases related to an imported case on April 15. The patients are the family members of an imported case from the United States, who was quarantined for 14 days upon arriving in China on March 24 and went home on April 8 after tested negative for the virus three times.